SpaceX IPO Could Become Largest in History with $1.8 Trillion Valuation Target 
MongoDB Q1 FY2027 Earnings Beat Expectations, Raises Full-Year Outlook 
Meta Subscription Push Could Add Billions in Recurring Revenue, Says Rosenblatt 
Nvidia and Microsoft to Launch AI-Powered Windows PCs at Computex 2026 
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments 
SoftBank to Invest €75 Billion in France AI Data Center Expansion by 2031 
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027 
Trump Adviser’s Investment in Thrive Capital Draws Scrutiny Over Federal Contracts 
Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements 
Universal Music Group Rejects Pershing Square Takeover Proposal 
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand 
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026 
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence 
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand 
Costco Q3 Fiscal 2026 Earnings Beat Expectations as Sales and E-Commerce Surge 
Rising Airfares May Challenge Cruise Industry Growth Ahead of 2027 Booking Season 
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
